Glucagon-like peptide-1 agonists, or GLP-1s, developed for diabetes patients By John Lovett Apr
American Society of Clinical Oncology (ASCO) Annual Meeting 2025
Have I met my deductible for the year
Different exercise modalities offer complementary benefits: Aerobic exercise (walking, cycling, swimming) performed regularly improves overall metabolic health and may enhance GLP-1 sensitivity Resistance training builds muscle mass, which increases metabolic rate and improves glucose disposal High-intensity interval training (HIIT) has shown promise for improving insulin sensitivity and metabolic markers The timing of exercise relative to meals may matter
[1] [5] While most GLP-1 medications are administered via subcutaneous injection (such as semaglutide, liraglutide, dulaglutide, or tirzepatide), with oral semaglutide (Rybelsus) as the only FDA-approved non-injectable option, transdermal patch delivery systems represent an emerging area of pharmaceutical development